VILLANI, ALESSIA
VILLANI, ALESSIA
Dipartimento di Medicina clinica e Chirurgia
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging
2023 Parisi, M.; Verrillo, M.; Luciano, M. A.; Caiazzo, G.; Quaranta, M.; Scognamiglio, F.; Di Meo, V.; Villani, A.; Cantelli, M.; Gallo, L.; Altobelli, G. G.; Poggi, S.; Spaccini, R.; Fabbrocini, G.
Reply to: "Usage and perceptions of teledermatology in 2021: a survey of dermatologists" by Ahmad et al
2023 Ruggiero, Angelo; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
Phototherapy and vitamin D: the importance in COVID-19 era
2022 Megna, Matteo; Fabbrocini, Gabriella; Villani, Alessia
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients
2022 Villani, A; Costa, C; Cappello, M; Fabbrocini, G; Scalvenzi, M
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al
2023 Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
2023 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
2022 Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185"
2022 Potestio, Luca; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
COVID-19 and cutaneous manifestations: A review of the published literature
2022 Martora, Fabrizio; Villani, Alessia; Fabbrocini, Gabriella; Battista, Teresa
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre
2022 Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Luigi; Guerrasio, Gianluca; di Vico, Francesca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Villani, Alessia
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department'
2022 Martora, Fabrizio; Ruggiero, Angelo; Fabbrocini, Gabriella; Villani, Alessia
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge
2022 Ruggiero, Angelo; Megna, Matteo; Fabbrocini, Gabriella; Fornaro, Luigi; Villani, Alessia
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al
2022 Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F
COVID-19 vaccination and inflammatory skin diseases
2022 Martora, Fabrizio; Villani, Alessia; Battista, Teresa; Fabbrocini, Gabriella; Potestio, Luca
Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment
2022 Ruggiero, Angelo; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic
2022 Villani, Alessia; Potestio, Luca; Fabbrocini, Gabriella; di Vico, Francesca; Costa, Claudia; Scalvenzi, Massimiliano
Cutaneous reactions following booster dose of Covid-19 mRNA vaccination: what we should know
2022 Potestio, Luca; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
Effects of COVID-19 pandemic on malignant melanoma diagnosis
2022 Villani, Alessia; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca
Maskne prevalence and risk factors during the COVID-19 pandemic
2022 Villani, A; Fabbrocini, G; Annunziata, M C; Potestio, L
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al
2022 Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Fabrizio; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Villani, Alessia
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging | 1.1 Articolo in rivista | 2023 | Parisi, M.; Verrillo, M.; Luciano, M. A.; Caiazzo, G.; Quaranta, M.; Scognamiglio, F.; Di Meo, V.; Villani, A.; Cantelli, M.; Gallo, L.; Altobelli, G. G.; Poggi, S.; Spaccini, R.; Fabbrocini, G. | |
| Reply to: "Usage and perceptions of teledermatology in 2021: a survey of dermatologists" by Ahmad et al | 1.7 Commento, erratum, replica e simili | 2023 | Ruggiero, Angelo; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
| Phototherapy and vitamin D: the importance in COVID-19 era | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Fabbrocini, Gabriella; Villani, Alessia | |
| The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients | 1.1 Articolo in rivista | 2022 | Villani, A; Costa, C; Cappello, M; Fabbrocini, G; Scalvenzi, M | |
| Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Villani, Alessia; Marasca, Claudio; Fabbrocini, Gabriella; Ruggiero, Angelo | |
| Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella | |
| The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca | |
| Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185" | 1.1 Articolo in rivista | 2022 | Potestio, Luca; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
| COVID-19 and cutaneous manifestations: A review of the published literature | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Villani, Alessia; Fabbrocini, Gabriella; Battista, Teresa | |
| The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Luigi; Guerrasio, Gianluca; di Vico, Francesca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Villani, Alessia | |
| Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department' | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Ruggiero, Angelo; Fabbrocini, Gabriella; Villani, Alessia | |
| Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Megna, Matteo; Fabbrocini, Gabriella; Fornaro, Luigi; Villani, Alessia | |
| Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al | 1.7 Commento, erratum, replica e simili | 2022 | Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F | |
| COVID-19 vaccination and inflammatory skin diseases | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Villani, Alessia; Battista, Teresa; Fabbrocini, Gabriella; Potestio, Luca | |
| Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
| Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic | 1.1 Articolo in rivista | 2022 | Villani, Alessia; Potestio, Luca; Fabbrocini, Gabriella; di Vico, Francesca; Costa, Claudia; Scalvenzi, Massimiliano | |
| Cutaneous reactions following booster dose of Covid-19 mRNA vaccination: what we should know | 1.1 Articolo in rivista | 2022 | Potestio, Luca; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
| Effects of COVID-19 pandemic on malignant melanoma diagnosis | 1.1 Articolo in rivista | 2022 | Villani, Alessia; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca | |
| Maskne prevalence and risk factors during the COVID-19 pandemic | 1.1 Articolo in rivista | 2022 | Villani, A; Fabbrocini, G; Annunziata, M C; Potestio, L | |
| Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al | 1.7 Commento, erratum, replica e simili | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Fabrizio; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Villani, Alessia |